Please wait while the formulary information is being retrieved.
PROLENSA (BROMFENAC SODIUM)
- Post-op ocular inflammation
- Postoperative ocular pain
0.07 % eye drops
- Instill 1 drop to the operated eye by ophthalmic route once daily start day prior to surgery, continue day of surgery and for next 2 weeks.
Post-op ocular inflammation
- Instill 1 drop to the operated eye by ophthalmic route once daily beginning 1 day prior to surgery, continued on day of surgery and throughthe first 2 weeks of post-operative period.
- Instill 1 drop to the operated eye by ophthalmic route once daily start day prior to surgery, continue day of surgery and for next 2 weeks.
Postoperative ocular pain
- Instill 1 drop to the operated eye by ophthalmic route once daily beginning 1 day prior to surgery, continued on day of surgery and throughthe first 2 weeks of post-operative period.
- Instill 1 drop to the operated eye by ophthalmic route once daily start day prior to surgery, continue day of surgery and for next 2 weeks.
- None
Contraindicated
- None
Severe
Moderate
- None
- None
Contraindicated
- None
Severe
Moderate
- Diabetes mellitus
- Epithelial keratopathy
- Ocular redness
- Rheumatoid arthritis
PROLENSA (BROMFENAC SODIUM)
- Post-op ocular inflammation
- Postoperative ocular pain
- None
- None
More Frequent
Severe
Less Severe
- Impaired wound healing
- Blurred vision
- Conjunctival hyperemia
- Foreign body sensation of eye
- Headache disorder
- Ocular hemorrhage
- Ocular irritation
- Ocular itching
- Ocular pain
- Ocular redness
- Photophobia
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- Corneal degeneration
- Corneal erosion
- Epithelial keratopathy
- Hyphema
- Iritis
- Keratitis
Less Severe
- None
Contraindicated
None
Severe Precaution
None
Management or Monitoring Precaution
Bromfenac (ophth)
Safety and efficacy not established in pediatrics.
- 1 Day – 18 Years
- Safety and efficacy not established in pediatrics.
Bromfenac (ophth)
- Severity Level:
C
- Additional Notes: Syst absorp unknown; not rec 3rd trimest, premature closure duct arteriosus risk
Contraindicated
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Precaution Exists
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
No Known Risk
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Contraindicated
None
Precaution Exists
None
No Known Risk
None
- None
| Post-op ocular inflammation | |
| H57.8 | Other specified disorders of eye and adnexa |
| Postoperative ocular pain | |
| H57.1 | Ocular pain |
| H57.10 | Ocular pain, unspecified eye |
| H57.11 | Ocular pain, right eye |
| H57.12 | Ocular pain, left eye |
| H57.13 | Ocular pain, bilateral |
| 0-9 | A-Z |
|---|---|
| H57.1 | Ocular pain |
| H57.10 | Ocular pain, unspecified eye |
| H57.11 | Ocular pain, right eye |
| H57.12 | Ocular pain, left eye |
| H57.13 | Ocular pain, bilateral |
| H57.8 | Other specified disorders of eye and adnexa |
Formulary Reference Tool